Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Madrigal Pharmaceuticals Inc (NQ: MDGL )

213.12 +9.82 (+4.83%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 412,128
Open 201.74
Bid (Size) 210.00 (1)
Ask (Size) 220.00 (2)
Prev. Close 203.30
Today's Range 196.00 - 213.56
52wk Range 57.21 - 322.67
Shares Outstanding 17,103,395
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money
These stocks just might have investors seeing double over the next few years. 
Via The Motley Fool
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,... 
Via Benzinga
Topics ETFs

Performance

YTD
-25.33%
-25.33%
1 Month
+55.11%
+55.11%
3 Month
+15.51%
+15.51%
6 Month
-20.04%
-20.04%
1 Year
+165.87%
+165.87%

More News

Read More
Madrigal Pharmaceuticals Stock Clears Benchmark, Hits 80+ RS Rating
Via Investor's Business Daily
The 3 Most Undervalued Biotech Stocks to Buy: November 2023
Via InvestorPlace
Analyst Ratings for Madrigal Pharmaceuticals
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Risky Stocks With Massive Potential
Via The Motley Fool
1 Beaten-Down Stock That Could Soar by 86%, According to Wall Street
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Nike, Carnival And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Nike, Carnival, Activision Blizzard, Madrigal Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today?
Via Benzinga
Topics Stocks
Exposures US Equities
Wall Street Thinks Madrigal Pharmaceuticals Could Climb 93%. Here's Why It Could Happen Soon.
Via The Motley Fool
Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
Via Benzinga
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 9/13 Morning Trading
Via Investor Brand Network
The Latest Analyst Ratings for Madrigal Pharmaceuticals
Via Benzinga
Madrigal Pharmaceuticals Surges As Its NASH Treatment Toes The Long-Awaited Finish Line
Via Investor's Business Daily
Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
The 3 Best Biotech Stocks to Buy Now: September 2023
Via InvestorPlace
3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of
Via InvestorPlace
The 3 Most Promising Pharma Stocks to Own Now
Via InvestorPlace
3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy?
Via The Motley Fool
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
Via The Motley Fool
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
Via The Motley Fool
Madrigal Stock Pops As It Makes Inroads Into What Could Be A $160 Billion Market
Via Investor's Business Daily
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.